1919 NEUTROPHIL-TO-LYMPHOCYTE RATIO REDUCTION AS A SURROGATE MARKER OF PROGNOSIS IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA RECEIVING SUNITINIB AS FIRST-LINE THERAPY

✍ Scribed by Park, Yong Hyun; Lee, Young Ju; Ku, Ja Hyeon; Kwak, Cheol; Kim, Hyeon Hoe

• Book ID: 122012306
• Publisher: Lippincott Williams and Wilkins
• Year: 2013
• Tongue: English
• Weight: 92 KB
• Volume: 189
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2013.02.2338